Rhythm Pharmaceuticals, Inc. (RYTM)
111.44
+1.44
(+1.31%)
USD |
NASDAQ |
Aug 24, 16:00
111.41
-0.03
(-0.03%)
After-Hours: 20:00
Rhythm Pharmaceuticals Market Cap : 7.669B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 7.669B |
| August 21, 2026 | 7.570B |
| August 20, 2026 | 7.496B |
| August 19, 2026 | 7.964B |
| August 18, 2026 | 7.931B |
| August 17, 2026 | 7.944B |
| August 14, 2026 | 7.947B |
| August 13, 2026 | 7.984B |
| August 12, 2026 | 8.093B |
| August 11, 2026 | 7.766B |
| August 10, 2026 | 7.947B |
| August 07, 2026 | 7.957B |
| August 06, 2026 | 7.714B |
| August 05, 2026 | 7.578B |
| August 04, 2026 | 7.240B |
| August 03, 2026 | 7.035B |
| July 31, 2026 | 6.793B |
| July 30, 2026 | 7.237B |
| July 29, 2026 | 7.291B |
| July 28, 2026 | 7.395B |
| July 27, 2026 | 7.264B |
| July 24, 2026 | 6.988B |
| July 23, 2026 | 7.027B |
| July 22, 2026 | 7.116B |
| July 21, 2026 | 7.296B |
| Date | Value |
|---|---|
| July 20, 2026 | 7.159B |
| July 17, 2026 | 7.296B |
| July 16, 2026 | 7.261B |
| July 15, 2026 | 7.508B |
| July 14, 2026 | 7.526B |
| July 13, 2026 | 7.357B |
| July 10, 2026 | 7.419B |
| July 09, 2026 | 7.904B |
| July 08, 2026 | 7.832B |
| July 07, 2026 | 7.834B |
| July 06, 2026 | 7.644B |
| July 02, 2026 | 7.814B |
| July 01, 2026 | 7.557B |
| June 30, 2026 | 7.599B |
| June 29, 2026 | 7.532B |
| June 26, 2026 | 7.518B |
| June 25, 2026 | 7.410B |
| June 24, 2026 | 7.361B |
| June 23, 2026 | 7.268B |
| June 22, 2026 | 6.940B |
| June 18, 2026 | 6.625B |
| June 17, 2026 | 6.559B |
| June 16, 2026 | 6.141B |
| June 15, 2026 | 6.140B |
| June 12, 2026 | 6.049B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.104B |
| Aprea Therapeutics, Inc. | 9.977M |
| Alnylam Pharmaceuticals, Inc. | 31.56B |
| Anika Therapeutics, Inc. | 285.59M |
| Savara, Inc. | 1.142B |
Market Cap Related Metrics
| PS Ratio | 31.32 |
| PEG Ratio | -10.80 |
| Price to Book Value | 74.47 |
| Price | 111.44 |
| Earnings Yield | -2.80% |
| PEGY Ratio | -10.80 |